Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Christine Radebaugh"'
Autor:
Mark A. Marzinke, Paul G. Richardson, Rahul P. Bakshi, Craig W. Hendrix, Laura McKinstry, Xin Li, Heather M.A. Prince, Deborah Donnell, Vanessa Elharrar, Angela D. M. Kashuba, Ruili Wang, Adriana Andrade, Peter L. Anderson, Kenneth H. Mayer, Eugenie Shieh, Christine Radebaugh, Lane R. Bushman, Ayana Moore, Ilene Wiggins, Namandjé N. Bumpus, Edward J. Fuchs, Kristine B. Patterson
Publikováno v:
AIDS Research and Human Retroviruses. 32:32-43
Oral preexposure prophylaxis (PrEP) trials report disparate efficacy attributed to variable adherence. HPTN 066 was conducted to establish objective, quantitative benchmarks for discrete, regular levels of adherence using directly observed dosing of
Autor:
Craig W. Hendrix, Hans M. L. Spiegel, Christine Radebaugh, Edward J. Fuchs, Lisa C. Rohan, Wutyi Aung, Mark A. Marzinke, Jennifer A. Robinson, Rahul P. Bakshi, Jenell S. Coleman
Publikováno v:
AIDS research and human retroviruses. 33(4)
While preexposure prophylaxis with oral tenofovir/emtricitabine reduces HIV acquisition rates, poor adherence to and acceptability of vaginal gels and the potential for evolving drug resistance have led to development of vaginal film formulations and
Autor:
Christine Radebaugh, Michelle L. Ray, Jennifer J. Kiser, Lane R. Bushman, Craig W. Hendrix, Edward J. Fuchs, Mark S. Sulkowski, Adriana Andrade
OBJECTIVES The objective of this study was to evaluate the effects of abacavir on intracellular ribavirin triphosphate and plasma ribavirin trough concentrations. METHODS Hepatitis C virus-infected subjects who had been cured or failed prior treatmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73010f559eb81158e9add51ce26985d1
https://europepmc.org/articles/PMC4867100/
https://europepmc.org/articles/PMC4867100/
Autor:
Patricia Barditch-Crovo, Christine Radebaugh, Wasif A. Khan, Paul A. Pham, Charles Flexner, Teresa L. Parsons, Kathryn A. Carson, Michelle Parish, Roula B Qaqish, Craig W. Hendrix, Gary E Pakes
Publikováno v:
Antiviral Therapy. 12:963-970
Background Amprenavir (APV), fosamprenavir (FPV), lopinavir (LPV), ritonavir (RTV) and efavirenz (EFV) are to varying degrees substrates, inducers and inhibitors of CYP3A4. Coadministration of these drugs might result in complex pharmacokinetic drug-
Autor:
Ying-Jun Cao, Patrick F Smith, Mary Beth Wire, Yu Lou, Charles T Lancaster, Roger C Causon, George E Bigelow, Elizabeth Martinez, Edward J Fuchs, Christine Radebaugh, Sarah McCabe, Craig W Hendrix
Publikováno v:
Pharmacotherapy. 28(7)
To compare steady-state pharmacokinetics and pharmacodynamics of methadone enantiomers when coadministered with fosamprenavir 700 mg-ritonavir 100 mg twice/day.Open-label, single-sequence, two-period crossover, drug-interaction study.Two university-a
Autor:
Angela D. M. Kashuba, Christine Radebaugh, Ron MacFarland, Jeanne Conley, Ying Jun Cao, Charles Flexner, Jeong-Gun Park, Craig W. Hendrix, Ilene Wiggins, Shelia Dunaway, Stephen Becker, Karin L. Klingman
Publikováno v:
Antimicrobial agents and chemotherapy. 52(5)
AMD070, a CXCR4 antagonist, has demonstrated antiretroviral activity in human immunodeficiency virus-infected patients. Since AMD070 is a substrate of cytochrome P450 3A4 and P-glycoprotein, both of which may be affected by ritonavir, we tested for a
Autor:
Ying Jun Cao, Brian Caffo, Craig W. Hendrix, Leena Choi, Edward J. Fuchs, Christine Radebaugh
Publikováno v:
Journal of clinical pharmacology. 48(2)
The accessory glands of the male genital tract are the sites of several major health problems, including benign prostatic hyperplasia, prostate cancer, and human immunodeficiency virus (HIV) transmission. We aimed to validate and improve our noninvas
Autor:
Paul A, Pham, Craig W, Hendrix, Patricia, Barditch-Crovo, Teresa, Parsons, Wasif, Khan, Michelle, Parish, Christine, Radebaugh, Kathryn A, Carson, Gary E, Pakes, Roula, Qaqish, Charles, Flexner
Publikováno v:
Antiviral therapy. 12(6)
Amprenavir (APV), fosamprenavir (FPV), lopinavir (LPV), ritonavir (RTV) and efavirenz (EFV) are to varying degrees substrates, inducers and inhibitors of CYP3A4. Coadministration of these drugs might result in complex pharmacokinetic drug-drug intera